Arpeggio Bio rakes in $3.2 mln seed

Boulder, Colorado-based Arpeggio Bio, a preclinical company, has raised $3.2 million in seed financing.

16 January 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles